CureVac NV (CVAC)
3.05
+0.06
(+2.01%)
USD |
NASDAQ |
Dec 26, 16:00
3.05
0.00 (0.00%)
After-Hours: 20:00
CureVac Profit Margin (Quarterly): 68.44% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioNTech SE | 15.91% |
| Bayer AG | -41.96% |
| Affimed NV | -9.77K% |
| InflaRx NV | -14.09K% |
| Immatics NV | -16.95% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.30% |
| Return on Assets | 15.24% |
| Return on Invested Capital | 21.30% |
| Gross Profit Margin (Quarterly) | 95.56% |
| Operating Margin (Quarterly) | 74.39% |
| Return on Net Operating Assets | 32.95% |